Hepatitis C is the most common bloodborne disease in the United States and is also the most frequent type of hepatitis we see in underwriting. What is it? An inflammation of the liver that may be acute and mild, or a more serious chronic type that attacks the liver.
Hep C virus (or HCV) is spread primarily through contact with blood of an infected person. It’s often called the “silent epidemic” because no symptoms are present until the disease progresses. If not identified early, it may lead to cirrhosis of the liver or liver cancer, which may require a transplant.
A few years ago, the outlook for treating chronic Hep C was less favorable. Patients would have to undergo protocols of injections and multiple pills a day with major side effects for almost a year. There would then be a six-month follow-up period to evaluate if treatment was a success. The cure rate was only 50 percent.
But, we’ve come a long way! Due to research in the field, many patients can now be cured with direct-acting antiviral drugs, a less potent combination in one or a few pills for only a few months. Cure rates are about 95 percent for most patients. FDA approved anti-viral drugs include Harvoni, Olysio, Viekira Pak, Zepatier and Daklinza. There also continues to be research for patients who don’t respond well to this new treatment protocol.
Depending on the type and specific details of a client’s hepatitis history, life insurance carriers will give possible consideration of coverage, some even qualifying without a rating. With the significantly improved cure rates associated with new treatments, we have seen several carriers update their risk philosophy specific to hepatitis with reduced/eliminated postpone periods after treatment and more clients qualifying for non-rated coverage.
Generally, the most favorable clients include those who have completed treatment with documented stability through interval lab testing, which shows normal liver function results (AST, ALT and GGT). Carriers also like to see an undetectable viral load (HCV RNA or HCV PCR), which measures the amount of virus in the bloodstream.
Important factors of consideration also include date of diagnosis, disease duration, liver biopsy results (if any), type of treatment (if any), date of last treatment, current/historic alcohol use and overall control/compliance of care.
To make your next case a little easier, view our Hepatitis Questionnaire with your client, then contact your Ash Brokerage team. We’re ready to help!
Lisa Oleski has been brokerage underwriting for the past 20 years. She is passionate about treating each case she touches as an opportunity to exemplify the Ash difference, with the ultimate outcome of finding the most favorable solutions for advisors and their clients.
Editor’s Note: We originally posted this simple, yet thoughtful post a year ago. Because it was so impactful, we decided to publish it again. This year, be sure you talk to your clients not just about their own independence, but the independence of their loved ones.
On the Fourth of July, we all think about having a day off from work, eating at cookouts, watching fireworks and just enjoying ourselves. It seems as though we’ve quickly forgotten about what the day really means: Independence.
Now I’m sure everyone reading this thinks I’m going to talk about your clients having the freedom and independence to receive long-term care where and how they want. To be honest, that’s the way I was going to go … Then I started thinking about my mother-in-law and all the struggles she and her siblings have gone through over the past few years as their parents required care … So please bear with me as I take a different approach.
When it comes to long-term care, I’ve written many times about the consequences family members suffer when their love one chooses to ignore the need for planning. What I’m saying is this: When someone needs extended care, they get it. But, those closest to them get new obligations which they may not be ready for. They are no longer a spouse, child or grandchild – they are likely caregivers, and their loved one is their patient.
While we all would happily sacrifice everything for our families (or at least I hope), would we ever ask our family members to do the same for us? The only logical answer is no, but clients seem to take this approach every single day. Ask them:
“If you have an extended care event, would you ask your spouse, children, grandchildren or other loved ones to give up their lives – their independence – to be your caregivers?”
The answer is probably no, but we typically don’t make our clients look at it this way.
As we celebrate our great nation’s independence, let’s change the way we have the conversation about long-term care. Let’s talk to our clients about giving their families freedom – freedom to continue to live their lives and not put everything on hold. Just a few simple questions will help them see things in a different light.
© 2018 Ash Brokerage LLC.